Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Nucleotide Regulation and Characteristics of Potassium Channel Opener Binding to Skeletal Muscle Membranes

K. E. J. Dickinson, C. C. Bryson, R. B. Cohen, L. Rogers, D. W. Green and K. S. Atwal
Molecular Pharmacology September 1997, 52 (3) 473-481; DOI: https://doi.org/10.1124/mol.52.3.473
K. E. J. Dickinson
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. C. Bryson
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. B. Cohen
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L. Rogers
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. W. Green
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. S. Atwal
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

[3H]P1075 binding to membrane preparations of rabbit skeletal muscle were observed in the presence of nucleotide triphosphates or diphosphates but not AMP, cAMP, adenosine, tripolyphosphate, or pyrophosphate. Nonhydrolyzable or poorly hydrolyzable ATP analogs inhibited MgATP-supported binding. The EC50 value for MgATP-supported binding (0.4 mm) was decreased ∼10-fold in the presence of an ATP-regenerating system, and significant metabolism by membrane nucleotidases was confirmed by high performance liquid chromatographic analysis. [3H]P1075 bound to skeletal muscle with aKd value of 37 ± 3 nm and a B max value of 280 ± 14 fmol/mg of protein. [3H]P1075 binding to subcellular fractions was highest in membranes enriched in T tubules. Specific binding was reversible, trypsin-sensitive, maximal at pH 8, and stereoselective for the (3S,4R)-enantiomer of cromakalim. Potassium channel openers exhibited a rank order of potency of P1075 > pinacidil > levcromakalim = BMS-180448 > nicorandil > diazoxide = BRL 38226. Fluorescein analogs (ethyleosin, phloxine B, and rose bengal) were relatively potent inhibitors of binding (Ki = 200–300 nm). The potassium channel openers cromakalim and BMS-180448 were competitive inhibitors of [3H]P1075 binding. In contrast, rose bengal and the ATP-regulated potassium channel antagonist glyburide increased the rate of [3H]P1075 dissociation in a manner consistent with noncompetitive interaction.

Footnotes

    • Received September 11, 1996.
    • Accepted May 14, 1997.
  • Send reprint requests to: Dr. K. E. J. Dickinson, Senior Research Investigator, Department Cardiovascular Pharmacology, Bristol-Myers Squibb P.R.I., P.O. Box 4000, Princeton, NJ 08543-4000. E-mail:dickinson_kenneth_e.prilvms3{at}msmail.bms.com

  • The American Society for Pharmacology and Experimental Therapeutics
View Full Text

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology: 52 (3)
Molecular Pharmacology
Vol. 52, Issue 3
1 Sep 1997
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Nucleotide Regulation and Characteristics of Potassium Channel Opener Binding to Skeletal Muscle Membranes
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Nucleotide Regulation and Characteristics of Potassium Channel Opener Binding to Skeletal Muscle Membranes

K. E. J. Dickinson, C. C. Bryson, R. B. Cohen, L. Rogers, D. W. Green and K. S. Atwal
Molecular Pharmacology September 1, 1997, 52 (3) 473-481; DOI: https://doi.org/10.1124/mol.52.3.473

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Research ArticleArticle

Nucleotide Regulation and Characteristics of Potassium Channel Opener Binding to Skeletal Muscle Membranes

K. E. J. Dickinson, C. C. Bryson, R. B. Cohen, L. Rogers, D. W. Green and K. S. Atwal
Molecular Pharmacology September 1, 1997, 52 (3) 473-481; DOI: https://doi.org/10.1124/mol.52.3.473
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Identification of Celecoxib targets by label-free TPP
  • Editing TOP2α Intron 19 5′ SS Circumvents Drug Resistance
  • CTS Bias
Show more Article

Similar Articles

  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics